The Global eClinical Solutions Market is expected to grow at a CAGR of around 9.7% from 2019 to 2026 and expected to reach the market value of around US$ 9,756 Mn by 2026.
The eclinical solutions refer to the development and offering of clinical technologies and expertise which are aimed at supporting the development of the clinical process. The eclinical solutions usually involve product solutions which include electronic data capture and clinical data management systems, clinical trial management systems, clinical analytics platforms, randomization, trial supply management, and clinical data integration platforms among others. The development of clinical trials and solutions has been a key component of the medical research industry ever since the outcomes of the very first clinical research were presented in the late 1950s. Clinical trials provide a base for fulfilling stringent drug approval processes which are made mandatory by the U.S. Food and Drug Administration (FDA). Clinical studies help in providing supportive research which is used to demonstrate the safety and efficiency of pharmaceutical drugs as well as medical devices. However, modern times have imparted more challenges for the pharmaceutical and medical device manufacturers, right from research & development to pricing and commercializing of products. Moreover, rising competition is forcing the industry players to innovate solutions that improve research & development efficiency while restoring profits.
The cost, risk, and time associated with the developing new treatment specifically drugs continue to increase due to stringent regulations and opportunities in orphan treatment. In such a situation, eClinical solutions help to minimize drug development costand risk by automating the clinical trial process. There are about 25 to 30 various application steps during the clinical trial workflow. By using these solutions, sponsors are able to manage increasing data volumes in a better way while facilitating the flexibility and speed needed for commercialization. Some of the solutions include ECOA,electronic data capture (EDC) and clinical data management system (CDMS), Clinical Analytics Platforms, Clinical data integration platforms, Safety solutions, Clinical Trial Management Systems (CTMS), Randomization and Trial Supply Management (RTSM), and Electronic Trial Master File (eTMF).
Market Dynamics
The global eclinical solutions industry is witnessing rapid growth owing to the increasing number of clinical trials in pharmaceutical drugs and medical devices research. Industry players prefer to outsource the eclinical solutions to developing nations which includes Korea, Taiwan, and India. A large number of the patient base which is coupled with lesser developing costs is considered a key factor for this development. Rising emphasis on effective and efficient research & development activities which are aimed at the development of modern eclinical solutions is another factor which is supporting the growth vector of the global market. Moreover, various initiatives and grants offered by the government are helping to boost the eclinical solutions industry.
Technological advancements such as Wi-Fi connectivity and electronic data capture are anticipated to propel the market during the forecast period. As the demand for collecting, storing, and analyzing clinical data increases, the need for clinical solutions enhances. Growing awareness about these clinical solutions and entry of various solutions by major market players are poised to drive the eClinical solutions market in the coming years.
Increasing adoption of eClinical solutions in trials and new product development offers enormous potential in clinical development processes. These solutions can simplify the decision making process in each phase of development. Advantages associated with these solutions such as the reduction in cost and time between development phase by utilizing seamless designs and by identifying failing compounds, rapid access to patient data and safety information is anticipated to boost the demand of eclinical solution.
Product Stance
Based on the product the market has been segmented into ECOA, EDC & CDMS, Clinical Analytics Platforms, Clinical data integration platforms, Safety solutions, CTMS, RTSM, and eTMF. The electronic data capture (EDC) and clinical data management system (CDMS) accounted for the maximum share of the eClinical solutions market in 2018. However, the electronic clinical outcome assessment (eCOA) is anticipated to observe the fastestgrowth during the forecast period. This can be attributed to the increasing importance of high-quality clinical data. Collecting data by using eCOA platforms enhance the quality of derived information, streamline data collection procedures, and offers effective data analysis.
Delivery Mode Analysis
Based on the delivery mode, eClinical solutions market is divided into the web-hosted, licensed enterprise (on-premise), and cloud-based mode. The web-hosted segment dominated the market in 2018 and is expected to maintain its dominance during the forecast period. This can be attributed to benefits associated with a delivery mode such as lower investment, easily customizable, a greater level of interoperability, and easy accessibility. The cloud-based system is anticipated to drive the market at the fastest rate in the coming years. Easy data backup and availability of real-time data are some of the advantages of a cloud-based system.
On the flip side, the high cost of research & development and implementation involved in eclinical solutions is likely to hamper the market growth. Additionally, the lack of skilled professionals in eclinical solutions industry is additionally expected to hinder the market growth. Whereas, the increasing investment in developing real-time analytics as compared to manual data analysis and the growing awareness in developing economies is anticipated to create potential opportunities over the forecast period.
By Clinical Trial Phase, Phase I Clinical Trials dominated the eclinical solutions market
In 2018, eclinical solutions made with Phase I Clinical Trials held the highest market share and the segment is also projected to maintain its dominance over the forecast period. The attributes which are supporting the growth of the segment is its capability to offer results related to safety, tolerability, pharmacokinetics and pharmacodynamics of the drug in cost effective way with lesser lead time.
The market research study on “eClinical Solutions Market– Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 – 2026”,offers a detailed insight into the global eclinical solutionsmarket entailing insights on its different market segments. Market dynamics with drivers, restraints, and opportunities with their impact are provided in the report. The report provides insights into the global eclinical solutions market, its product, delivery mode, clinical trial phase, end-use, and major geographic regions. The report covers basic development policies and layouts of technology development processes. Secondly, the report covers global eclinical solutions market size and volume, and segment markets by product, delivery mode, clinical trial phase, end-use, and geography along with the information on companies operating in the market. The eclinical solutions market analysis is provided for major regional markets including North America, Europe, Asia Pacific, Latin America and Middle East and Africa. For each region, the market size and volume for different segments have been covered under the scope of the report.
In 2018, North America dominated the regional market with a maximum market share
North America accounted for the high market share of the eclinical solutions market and the region is also expected to maintain its dominance over the forecast period. The region is experiencing the maximum growth owing to the presence of eclinical solutions industry players, favorable government initiatives, and an increasing number of clinical trials undertaking to provide solutions to the lifestyle-related diseases in the region. North America is followed by the Europe region in the eclinical solutions market.
The players profiled in the report include Oracle Corporation, Medidata Solutions, Inc., Parexel International Corporation, Bioclinica, Inc. (A Subsidiary of Cinven), Datatrak International, Inc., CRF Health, ERT Clinical, Merge Healthcare Incorporated, Omnicomm Systems, Inc., Maxisit Inc., Bio-Optronics, Inc., and Eclinical Solutions, LLC. The companies are involved in mergers and acquisitions and new product development for expanding their market share and also for gaining competitive advantages over its competitors.
Market Segmentation
Market by Product
- Electronic Data Capture and Clinical Data Management Systems
- Clinical Trial Management Systems
- Clinical Analytics Platforms
- Randomization and Trial Supply Management
- Clinical Data Integration Platforms
- Electronic Clinical Outcome Assessment Solutions
- Safety Solutions
- Electronic Trial Master File Systems
- Regulatory Information Management Solutions
- Others
Market by Delivery Mode
- Web-Hosted (On-Demand) Solutions
- Licensed Enterprise (On-Premise) Solutions
- Cloud-Based (SaaS) Solutions
Market by Clinical Trial Phase
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV Clinical Trials
Market by End-use
- Pharmaceutical and Biopharmaceutical Companies
- Contract Research Organizations
- Consulting Service Companies
- Medical Device Manufacturers
- Hospitals
- Academic Research Institutes
Market By Geography
- North America
- Europe
- UK
- Germany
- France
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Table Of Content
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of eClinical Solutions
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. eClinical Solutions Market By Product
1.2.2.1. Global eClinical Solutions Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global eClinical Solutions Market Revenue Share By Product in 2018
1.2.2.3. Electronic Data Capture and Clinical Data Management Systems
1.2.2.4. Clinical Trial Management Systems
1.2.2.5. Clinical Analytics Platforms
1.2.2.6. Randomization and Trial Supply Management
1.2.2.7. Clinical Data Integration Platforms
1.2.2.8. Electronic Clinical Outcome Assessment Solutions
1.2.2.9. Safety Solutions
1.2.2.10. Electronic Trial Master File Systems
1.2.2.11. Regulatory Information Management Solutions
1.2.2.12. Others
1.2.3. eClinical Solutions Market By Delivery Mode
1.2.3.1. Global eClinical Solutions Market Revenue and Growth Rate Comparison By Delivery Mode (2015-2026)
1.2.3.2. Web-Hosted (On-Demand) Solutions
1.2.3.3. Licensed Enterprise (On-Premise) Solutions
1.2.3.4. Cloud-Based (SaaS) Solutions
1.2.4. eClinical Solutions Market By Clinical Trial Phase
1.2.4.1. Global eClinical Solutions Market Revenue and Growth Rate Comparison By Clinical Trial Phase (2015-2026)
1.2.4.2. Phase I Clinical Trials
1.2.4.3. Phase II Clinical Trials
1.2.4.4. Phase III Clinical Trials
1.2.4.5. Phase IV Clinical Trials
1.2.5. eClinical Solutions Market By End-use
1.2.5.1. Global eClinical Solutions Market Revenue and Growth Rate Comparison By End-user (2015-2026)
1.2.5.2. Pharmaceutical and Biopharmaceutical Companies
1.2.5.3. Contract Research Organizations
1.2.5.4. Consulting Service Companies
1.2.5.5. Medical Device Manufacturers
1.2.5.6. Hospitals
1.2.5.7. Academic Research Institutes
1.2.6. eClinical Solutions Market By Geography
1.2.6.1. Global eClinical Solutions Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.6.2. North America eClinical Solutions Market Revenue and Growth Rate(2015-2026)
1.2.6.3. Europe eClinical Solutions Market Revenue and Growth Rate(2015-2026)
1.2.6.4. Asia-Pacific eClinical Solutions Market Revenue and Growth Rate(2015-2026)
1.2.6.5. Latin America eClinical Solutions Market Revenue and Growth Rate(2015-2026)
1.2.6.6. Middle East and Africa (MEA) eClinical Solutions Market Revenue and Growth Rate(2015-2026)
CHAPTER 2. MARKET DYNAMICSAND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global eClinical Solutions Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global eClinical Solutions Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global eClinical Solutions Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global eClinical Solutions Major Manufacturers in 2018
CHAPTER 4. ECLINICAL SOLUTIONS MARKET BY PRODUCT
4.1. Global eClinical Solutions Revenue By Product
4.2. Electronic Data Capture and Clinical Data Management Systems
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Clinical Trial Management Systems
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Clinical Analytics Platforms
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Randomization and Trial Supply Management
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Clinical Data Integration Platforms
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.7. Electronic Clinical Outcome Assessment Solutions
4.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.8. Safety Solutions
4.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.9. Electronic Trial Master File Systems
4.9.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.9.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.10. Regulatory Information Management Solutions
4.10.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.10.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.11. Others
4.11.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.11.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 5. ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE
5.1. Global eClinical Solutions Revenue By Delivery Mode
5.2. Web-Hosted (On-Demand) Solutions
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Licensed Enterprise (On-Premise) Solutions
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Cloud-Based (SaaS) Solutions
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 6. ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE
6.1. Global eClinical Solutions Revenue By Clinical Trial Phase
6.2. Phase I Clinical Trials
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Phase II Clinical Trials
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Phase III Clinical Trials
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Phase IV Clinical Trials
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 7. ECLINICAL SOLUTIONS MARKET By End-use
7.1. Global eClinical Solutions Revenue By End-use
7.2. Pharmaceutical and Biopharmaceutical Companies
7.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.3. Contract Research Organizations
7.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.4. Consulting Service Companies
7.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.5. Medical Device Manufacturers
7.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.6. Hospitals
7.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.7. Academic Research Institutes
7.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 8. NORTH AMERICA ECLINICAL SOLUTIONS MARKET BY COUNTRY
8.1. North America eClinical Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. North America eClinical Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. U.S.
8.3.1. U.S. eClinical Solutions Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
8.3.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
8.4. Canada
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
8.4.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
CHAPTER 9. EUROPE ECLINICAL SOLUTIONS MARKET BY COUNTRY
9.1. Europe eClinical Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Europe eClinical Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. UK
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
9.3.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.4. Germany
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
9.4.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.5. France
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
9.5.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.6. Spain
9.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
9.6.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.7. Rest of Europe
9.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
9.7.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
CHAPTER 10. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET BY COUNTRY
10.1. Asia-Pacific eClinical Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Asia-Pacific eClinical Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. China
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
10.3.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.4. Japan
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
10.4.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.5. India
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
10.5.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.6. Australia
10.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.6.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
10.6.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
10.6.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.7. South Korea
10.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.7.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
10.7.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
10.7.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.8. Rest of Asia-Pacific
10.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.8.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
10.8.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
10.8.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
CHAPTER 11. LATIN AMERICA ECLINICAL SOLUTIONS MARKET BY COUNTRY
11.1. Latin America eClinical Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Latin America eClinical Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Brazil
11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
11.3.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
11.4. Mexico
11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
11.4.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
11.5. Rest of Latin America
11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
11.5.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
CHAPTER 12. MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET BY COUNTRY
12.1. Middle East & Africa eClinical Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Middle East & Africa eClinical Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. GCC
12.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
12.3.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
12.4. South Africa
12.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
12.4.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
12.5. Rest of Middle East & Africa
12.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
12.5.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
CHAPTER 13. COMPANY PROFILE
13.1. Oracle Corporation
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Medidata Solutions, Inc.
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Parexel International Corporation
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Bioclinica, Inc. (A Subsidiary of Cinven)
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Datatrak International, Inc.
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. CRF Health
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. ERT Clinical
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Merge Healthcare Incorporated
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Omnicomm Systems, Inc.
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Maxisit Inc.
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies
13.11. Bio-Optronics, Inc.
13.11.1. Company Snapshot
13.11.2. Overview
13.11.3. Financial Overview
13.11.4. Type Portfolio
13.11.5. Key Developments
13.11.6. Strategies
13.12. Others
13.12.1. Company Snapshot
13.12.2. Overview
13.12.3. Financial Overview
13.12.4. Type Portfolio
13.12.5. Key Developments
13.12.6. Strategies
CHAPTER 14. RESEARCH APPROACH
14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope
